Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...

As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...

European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.

Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, agrees. “Lowering a person’s ...

Novo Nordisk (NVO) offered investors an update about ongoing cost-cutting efforts as copycat weight-loss drugs weigh on sales ...

Lizzo opened up about her dramatic weight loss in a recent interview, and the singer says that even though she’s dropped down ...

Once aimed at diabetes patients, drugs like Ozempic are famous for bringing about rapid weight loss. But the injections often ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--had been in short supply as the company raced to increase production and meet surging demand. But the drug came off ...

President Donald Trump provided new details about his plan to impose tariffs on foreign-made pharmaceuticals, but the White ...

"I like how I look now. I still think I’m big. I’m still wearing plus-size clothing. I have the same rolls," the singer ...